Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Meningeal Carcinomatosis × lorlatinib × Clear all

Status

Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 5 Non Small Cell Lung Cancer Metastatic 1 Meningeal Carcinomatosis 1 Lung Neoplasms 1 Brain Neoplasms 1 Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer 1

Interventions

toripalimab 1 lorlatinib 1 adavosertib 1 Radiotherapy 1 Radiation 1 Pemetrexed 1 Immunotherapy, Adoptive 1 GDC-0084 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06410040 2024-05-10

A Retrospective Study of the Efficacy and Safety of Lolatinib in ALK+ NSCLC Patients With Brain or Meningeal Metastasis

Sichuan Cancer Hospital and Research Institute

Active not recruiting

Brain Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡